1. Home
  2. EGY vs CSTL Comparison

EGY vs CSTL Comparison

Compare EGY & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VAALCO Energy Inc.

EGY

VAALCO Energy Inc.

HOLD

Current Price

$6.28

Market Cap

652.2M

Sector

Energy

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$32.42

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EGY
CSTL
Founded
1985
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
652.2M
722.8M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
EGY
CSTL
Price
$6.28
$32.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$10.20
★ $45.22
AVG Volume (30 Days)
★ 1.1M
333.4K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
★ 4.03%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $359,272,000.00
$344,229,000.00
Revenue This Year
$24.31
$8.49
Revenue Next Year
$14.62
$10.44
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$3.36
$17.72
52 Week High
$6.72
$44.28

Technical Indicators

Market Signals
Indicator
EGY
CSTL
Relative Strength Index (RSI) 61.25 43.03
Support Level $5.02 $31.44
Resistance Level $6.67 $34.23
Average True Range (ATR) 0.17 1.75
MACD 0.04 -0.40
Stochastic Oscillator 94.33 7.44

Price Performance

Historical Comparison
EGY
CSTL

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: